Skip to content

Ocular Therapeutix OCUL Inventory turnover

Inventory turnover at other companies

HRO
HarrowHROW
5.1×+0.1×
PBH
Prestige Consumer HealthcarePBH
3.2×-0.3×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
2.2×-0.1×
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
1.4×-0.3×
LQD
Liquidia CorporationLQDA
2.4×
Glaukos logo
GlaukosGKOS
+0.2×

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Calculated from Ocular Therapeutix’s reported figures.

Based on trailing twelve months.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's inventory turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's inventory turnover?
Ocular Therapeutix (OCUL) reported inventory turnover of 1.9× in Q1 2026.
How has Ocular Therapeutix's inventory turnover changed year-over-year?
Ocular Therapeutix's inventory turnover decreased by 0.4% year-over-year, from 1.9× to 1.9×.
What is the long-term trend for Ocular Therapeutix's inventory turnover?
Over 5 years (2020 to 2025), Ocular Therapeutix's inventory turnover has grown at a 0.6% compound annual growth rate (CAGR), from 1.9× to 2×.
What does inventory turnover mean?
Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.